Jonathan Cargo
Optometrist · Irving, TXNPI 1134154206
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $95,075 of the $137,947 with a category attached, or 68.9%. Bausch & Lomb Americas Inc. accounts for 67.4% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $33,399, 2.6 times the $12,841 reported in 2019. Among optometrist clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 378 payments — averaging $364.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$93K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$41K
- Alcon$2K
- Coopervision Inc.$843
- Optos, Inc.$438
- LKC Technologies, Inc.$338
- plus $1K from 10 others
What the payments were for
- Consulting fees$11,2008%
- Speaking & faculty fees$95,07569%
- Travel & lodging$18,13313%
- Food & beverage$13,33010%
- Entertainment$2090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 199 | $93,023 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 100 | $40,514 |
| Alcon | 37 | $1,762 |
| Coopervision Inc. | 12 | $843 |
| Optos, Inc. | 8 | $438 |
| LKC Technologies, Inc. | 3 | $338 |
| Glaukos Corporation | 3 | $275 |
| Johnson & Johnson Vision Care, Inc. | 2 | $153 |
| ABB Con-cise Optical Group LLC | 2 | $132 |
| Sanofi | 1 | $122 |
| AbbVie | 3 | $122 |
| Novartis | 4 | $99 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $48 |
| Sight Sciences, Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $27 |
| Tarsus Pharmaceuticals, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$90,386
- INFUSE MULTIFOCAL$13,997
- BIOTRUE$13,836
- ULTRA$11,268
- ULTRA MULTIFOCAL TORIC$10,298
- BIOTRUE ONE DAY$9,951
- MULTI-FOCAL$2,124
- PANORAMIC OPHTHALMOSCOPE$459
- OCT OPHTHALMOSCOPE$356
- MyDay Contact Lens$318
- TOTAL30$282
- Precision7$231
- NFC-700$229
- Precision 1$147
- DAILIES TOTAL1$144
- RADIUS$137
- BTOD$124
- Acuvue$124
- CERDELGA$122
- FABRAZYME$122
How this compares
$137,947 in reported general payments places this provider in the 95th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 23 | $25,369 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 20 | $4,690 |
| VyzultaLatanoprostene Bunod | 11 | $4,186 |
| CombiganBrimonidine Tartrate/Timolol | 12 | $2,457 |
| Travoprost | 13 | $1,531 |
| Latanoprost | 23 | $170 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Combigan | $122 | $27,82635 claims |
| AlconSimbrinza | $1,762 | $4,69020 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $93,023 | $4,18611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,315 optometrist providers in Texas.
Other optometrist in Irving
- Derek CunninghamAustin$940K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$547K
- Luis RojasMcKinney$309K
- Emile FadelAustin$225K
- Bridgitte LeeHouston$222K
- Phillip BrunsonHouston$214K
- Jill AutryBellaire$171K
- Stacie VirdenWaco$164K
- Richard PotvinBurleson$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.